MXCT compared with SKIN: revenue, margins and what each company keeps, and the suppliers and customers both name

MXCTMaxcyte, Inc.

Mkt capRevenueRevenue

SKINSkinHealth Systems Inc.

Mkt capRevenueRevenue

Compare

MXCTMaxcyte, Inc.

SKINSkinHealth Systems Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

MXCT: latest quarter is a loss; flow not drawable. SKIN: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

MXCT, solidSKIN, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MXCT 5

TGTXTG Therapeuticscustomer

DTILPrecision BioSciencescustomer

—SeQure Dxunlistedsupplier

—Imugene (USA)unlistedcustomer

1 more · MXCT chain ›

Shared 0

No disclosed counterparties: SKIN.

Only SKIN 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

MXCTMaxcyte, Inc.

1.57▼−9.25%· post 1.57

Mkt cap$164.1MRevenue$7MQ2 FY26Revenue$33MFY25

SKINSkinHealth Systems Inc.

9.96▼−1.83%· post 9.96

ClosedOct 30 '26

Mkt cap$64.7MRevenue$72MQ2 FY26Revenue$301MFY25

Compare

ClosedOct 30 '26

MXCTMaxcyte, Inc.

SKINSkinHealth Systems Inc.

1.57▼−9.25%post 1.57

Price

9.96▼−1.83%post 9.96

$164.1M

Mkt cap

$64.7M

Q2 FY26$7M

Revenue

$72MQ2 FY26

FY25$33M

Revenue

$301MFY25

MXCT1.57▼−9.25%vsSKIN9.96▼−1.83%ClosedOct 30 '26